Surgical & Medical Instruments & Apparatus
Artivion, Inc. (AORT) stock: what's happening now, every material event decoded in plain English, P/E and valuation, analyst ratings, and insider buying and selling.
AllSight quality score: 41/100 — a percentile rank of Artivion, Inc.’s fundamentals against Manufacturing peers.
Is Artivion, Inc. overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks undervalued vs its 5-year range.
Consensus: Buy from 12 analysts (Buy 10 · Hold 2).
Average price target: $35.33 (+90.7% vs $18.53); range $30–$45.
Wall Street analyst consensus, shown as context — not an AllSight view.
Open-market buys: 2 · Open-market sells: 93 · Net: −$22.1M
Discretionary open-market purchases are the signal; grants, option exercises and Rule 10b5-1 scheduled trades are context, not counted in the balance. Facts only — not a recommendation. Source: SEC Form 4 filings on EDGAR.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!